{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T09:33:14Z","timestamp":1779183194913,"version":"3.51.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T00:00:00Z","timestamp":1659484800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T00:00:00Z","timestamp":1659484800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Indonesian Endowment Fund for Education","award":["S-1598\/LPDP.3\/2016"],"award-info":[{"award-number":["S-1598\/LPDP.3\/2016"]}]},{"name":"Leiden University Medical Center Strategic Fund for Leiden Controlled Human Infection Center"},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01GM9987654"],"award-info":[{"award-number":["R01GM9987654"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001713","name":"European and Developing Countries Clinical Trials Partnership","doi-asserted-by":"publisher","award":["SP.2011.41304.062"],"award-info":[{"award-number":["SP.2011.41304.062"]}],"id":[{"id":"10.13039\/501100001713","id-type":"DOI","asserted-by":"publisher"}]},{"name":"German Ministry of Education and Research"},{"DOI":"10.13039\/501100005040","name":"Bontius Stichting","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005040","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Stichting Tabernaleporis"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Controlled human malaria infection (CHMI) using cryopreserved non-attenuated Plasmodium falciparum sporozoites (PfSPZ) offers a unique opportunity to investigate naturally acquired immunity (NAI). By analyzing blood samples from 5 malaria-na\u00efve European and 20 African adults with lifelong exposure to malaria, before, 5, and 11\u00a0days after direct venous inoculation (DVI) with Sanaria<jats:sup>R<\/jats:sup> PfSPZ Challenge, we assessed the immunological patterns associated with control of microscopic and submicroscopic parasitemia. All (5\/5) European individuals developed parasitemia as defined by thick blood smear (TBS), but 40% (8\/20) of the African individuals controlled their parasitemia, and therefore remained thick blood smear-negative (TBS<jats:sup>\u2212<\/jats:sup> Africans). In the TBS<jats:sup>\u2212<\/jats:sup> Africans, we observed higher baseline frequencies of CD4<jats:sup>+<\/jats:sup> T cells producing interferon-gamma (IFN\u03b3) that significantly decreased 5\u00a0days after PfSPZ DVI. The TBS<jats:sup>\u2212<\/jats:sup> Africans, which represent individuals with either very strong and rapid blood-stage immunity or with immunity to liver stages, were stratified into subjects with sub-microscopic parasitemia (TBS<jats:sup>-<\/jats:sup>PCR<jats:sup>+<\/jats:sup>) or those with possibly sterilizing immunity (TBS<jats:sup>\u2212<\/jats:sup>PCR<jats:sup>\u2212<\/jats:sup>). Higher frequencies of IFN\u03b3<jats:sup>+<\/jats:sup>TNF<jats:sup>+<\/jats:sup>CD8<jats:sup>+<\/jats:sup> \u03b3\u03b4 T cells at baseline, which later decreased within five days after PfSPZ DVI, were associated with those who remained TBS<jats:sup>\u2212<\/jats:sup>PCR<jats:sup>\u2212<\/jats:sup>. These findings suggest that naturally acquired immunity is characterized by different cell types that show varying strengths of malaria parasite control. While the high frequencies of antigen responsive IFN\u03b3<jats:sup>+<\/jats:sup>CD4<jats:sup>+<\/jats:sup> T cells in peripheral blood keep the blood-stage parasites to a sub-microscopic level, it is the IFN\u03b3<jats:sup>+<\/jats:sup>TNF<jats:sup>+<\/jats:sup>CD8<jats:sup>+<\/jats:sup> \u03b3\u03b4 T cells that are associated with either immunity to the liver-stage, or rapid elimination of blood-stage parasites.<\/jats:p>","DOI":"10.1038\/s41598-022-17725-8","type":"journal-article","created":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T10:02:39Z","timestamp":1659520959000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Immunological profiles associated with distinct parasitemic states in volunteers undergoing malaria challenge in Gabon"],"prefix":"10.1038","volume":"12","author":[{"given":"Mikhael D.","family":"Manurung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanne E.","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvonne","family":"Kruize","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoanne D.","family":"Mouwenda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madeleine Eunice Betouke","family":"Ongwe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yabo Josiane","family":"Honkpehedji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeannot Fr\u00e9zus","family":"Zinsou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean Claude","family":"Dejon-Agobe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen L.","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter G.","family":"Kremsner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayola Akim","family":"Adegnika","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolf","family":"Fendel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Mordm\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meta","family":"Roestenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bertrand","family":"Lell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Yazdanbakhsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,3]]},"reference":[{"key":"17725_CR1","volume-title":"World Malaria Report 2020","author":"WHO","year":"2020","unstructured":"WHO. World Malaria Report 2020 (WHO, 2020)."},{"key":"17725_CR2","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/s1473-3099(17)30104-4","volume":"17","author":"MS Sissoko","year":"2017","unstructured":"Sissoko, M. S. et al. Safety and efficacy of PfSPZ Vaccine against Plasmodium falciparum via direct venous inoculation in healthy malaria-exposed adults in Mali: A randomised, double-blind phase 1 trial. Lancet. Infect. Dis. 17, 498\u2013509. https:\/\/doi.org\/10.1016\/s1473-3099(17)30104-4 (2017).","journal-title":"Lancet. Infect. Dis."},{"key":"17725_CR3","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1093\/infdis\/jiw237","volume":"214","author":"JA Regules","year":"2016","unstructured":"Regules, J. A. et al. Fractional third and fourth dose of RTS, S\/AS01 malaria candidate vaccine: A Phase 2A controlled human malaria parasite infection and immunogenicity study. J. Infect. Dis. 214, 762\u2013771. https:\/\/doi.org\/10.1093\/infdis\/jiw237 (2016).","journal-title":"J. Infect. Dis."},{"key":"17725_CR4","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1128\/IAI.03069-14","volume":"83","author":"JM Obiero","year":"2015","unstructured":"Obiero, J. M. et al. Impact of malaria preexposure on antiparasite cellular and humoral immune responses after controlled human malaria infection. Infect. Immun. 83, 2185\u20132196. https:\/\/doi.org\/10.1128\/IAI.03069-14 (2015).","journal-title":"Infect. Immun."},{"key":"17725_CR5","doi-asserted-by":"publisher","first-page":"508","DOI":"10.4269\/ajtmh.17-0343","volume":"98","author":"B Lell","year":"2018","unstructured":"Lell, B. et al. Impact of sickle cell trait and naturally acquired immunity on uncomplicated malaria after controlled human malaria infection in adults in Gabon. Am. J. Trop. Med. Hyg. 98, 508\u2013515. https:\/\/doi.org\/10.4269\/ajtmh.17-0343 (2018).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"17725_CR6","doi-asserted-by":"publisher","first-page":"11487","DOI":"10.1038\/s41598-017-10624-3","volume":"7","author":"P Jagannathan","year":"2017","unstructured":"Jagannathan, P. et al. V\u03b42+ T cell response to malaria correlates with protection from infection but is attenuated with repeated exposure. Sci. Rep. 7, 11487. https:\/\/doi.org\/10.1038\/s41598-017-10624-3 (2017).","journal-title":"Sci. Rep."},{"key":"17725_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003864","volume":"10","author":"P Jagannathan","year":"2014","unstructured":"Jagannathan, P. et al. IFN\u03b3\/IL-10 co-producing cells dominate the CD4 response to malaria in highly exposed children. PLoS Pathog. 10, e1003864. https:\/\/doi.org\/10.1371\/journal.ppat.1003864 (2014).","journal-title":"PLoS Pathog."},{"key":"17725_CR8","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1017\/S0031182015001092","volume":"143","author":"DI Stanisic","year":"2016","unstructured":"Stanisic, D. I. & Good, M. F. Examining cellular immune responses to inform development of a blood-stage malaria vaccine. Parasitology 143, 208\u2013223. https:\/\/doi.org\/10.1017\/S0031182015001092 (2016).","journal-title":"Parasitology"},{"key":"17725_CR9","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/192733a0","volume":"192","author":"S Cohen","year":"1961","unstructured":"Cohen, S., McGregor, I. A. & Carrington, S. Gamma-globulin and acquired immunity to human malaria. Nature 192, 733\u2013737. https:\/\/doi.org\/10.1038\/192733a0 (1961).","journal-title":"Nature"},{"key":"17725_CR10","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/j.immuni.2017.11.007","volume":"47","author":"G Triller","year":"2017","unstructured":"Triller, G. et al. Natural parasite exposure induces protective human anti-malarial antibodies. Immunity 47, 1197-1209.e1110. https:\/\/doi.org\/10.1016\/j.immuni.2017.11.007 (2017).","journal-title":"Immunity"},{"key":"17725_CR11","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41577-019-0158-z","volume":"19","author":"SP Kurup","year":"2019","unstructured":"Kurup, S. P., Butler, N. S. & Harty, J. T. T cell-mediated immunity to malaria. Nat. Rev. Immunol. 19, 457\u2013471. https:\/\/doi.org\/10.1038\/s41577-019-0158-z (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"17725_CR12","doi-asserted-by":"publisher","first-page":"6043","DOI":"10.4049\/jimmunol.1000106","volume":"184","author":"A Horowitz","year":"2010","unstructured":"Horowitz, A. et al. Cross-talk between T cells and nk cells generates rapid effector responses toplasmodium falciparum-infected erythrocytes. J. Immunol. 184, 6043\u20136052. https:\/\/doi.org\/10.4049\/jimmunol.1000106 (2010).","journal-title":"J. Immunol."},{"key":"17725_CR13","doi-asserted-by":"publisher","first-page":"4399","DOI":"10.1128\/IAI.68.8.4399-4406.2000","volume":"68","author":"Z Su","year":"2000","unstructured":"Su, Z. & Stevenson, M. M. Central role of endogenous gamma interferon in protective immunity against blood-stage Plasmodium chabaudi AS infection. Infect. Immun. 68, 4399\u20134406. https:\/\/doi.org\/10.1128\/IAI.68.8.4399-4406.2000 (2000).","journal-title":"Infect. Immun."},{"key":"17725_CR14","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1084\/jem.180.1.353","volume":"180","author":"MC Seguin","year":"1994","unstructured":"Seguin, M. C. et al. Induction of nitric oxide synthase protects against malaria in mice exposed to irradiated Plasmodium berghei infected mosquitoes: Involvement of interferon gamma and CD8+ T cells. J. Exp. Med. 180, 353\u2013358. https:\/\/doi.org\/10.1084\/jem.180.1.353 (1994).","journal-title":"J. Exp. Med."},{"key":"17725_CR15","doi-asserted-by":"publisher","first-page":"3781","DOI":"10.4049\/jimmunol.1700314","volume":"199","author":"I Zaidi","year":"2017","unstructured":"Zaidi, I. et al. \u03b3\u03b4 T cells are required for the induction of sterile immunity during irradiated sporozoite vaccinations. J. Immunol. 199, 3781\u20133788. https:\/\/doi.org\/10.4049\/jimmunol.1700314 (2017).","journal-title":"J. Immunol."},{"key":"17725_CR16","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1046\/j.1365-3083.1999.00647.x","volume":"50","author":"M Troye-Blomberg","year":"1999","unstructured":"Troye-Blomberg, M. et al. Human \u03b3\u03b4T cells that inhibit the in vitro growth of the asexual blood stages of the Plasmodium falciparum parasite express cytolytic and proinflammatory molecules. Scand. J. Immunol. 50, 642\u2013650. https:\/\/doi.org\/10.1046\/j.1365-3083.1999.00647.x (1999).","journal-title":"Scand. J. Immunol."},{"key":"17725_CR17","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/s41590-021-00911-7","volume":"22","author":"SE De Jong","year":"2021","unstructured":"De Jong, S. E. et al. Systems analysis and controlled malaria infection in Europeans and Africans elucidate naturally acquired immunity. Nat. Immunol. 22, 654\u2013665. https:\/\/doi.org\/10.1038\/s41590-021-00911-7 (2021).","journal-title":"Nat. Immunol."},{"key":"17725_CR18","doi-asserted-by":"publisher","first-page":"97","DOI":"10.4161\/hv.6.1.10396","volume":"6","author":"SL Hoffman","year":"2010","unstructured":"Hoffman, S. L. et al. Development of a metabolically active, non-replicating sporozoite vaccine to preventPlasmodium falciparummalaria. Hum. Vaccines 6, 97\u2013106. https:\/\/doi.org\/10.4161\/hv.6.1.10396 (2010).","journal-title":"Hum. Vaccines"},{"key":"17725_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002389","volume":"7","author":"AC Teirlinck","year":"2011","unstructured":"Teirlinck, A. C. et al. Longevity and composition of cellular immune responses following experimental Plasmodium falciparum malaria infection in humans. PLoS Pathog. 7, e1002389. https:\/\/doi.org\/10.1371\/journal.ppat.1002389 (2011).","journal-title":"PLoS Pathog."},{"key":"17725_CR20","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/1471-2105-10-106","volume":"10","author":"F Hahne","year":"2009","unstructured":"Hahne, F. et al. flowCore: A Bioconductor package for high throughput flow cytometry. BMC Bioinform. 10, 106. https:\/\/doi.org\/10.1186\/1471-2105-10-106 (2009).","journal-title":"BMC Bioinform."},{"key":"17725_CR21","doi-asserted-by":"publisher","first-page":"861","DOI":"10.21105\/joss.00861","volume":"3","author":"L McInnes","year":"2018","unstructured":"McInnes, L., Healy, J., Saul, N. & Gro\u00dfberger, L. UMAP: Uniform manifold approximation and projection. J. Open Source Softw. 3, 861. https:\/\/doi.org\/10.21105\/joss.00861 (2018).","journal-title":"J. Open Source Softw."},{"key":"17725_CR22","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","volume":"32","author":"Z Gu","year":"2016","unstructured":"Gu, Z., Eils, R. & Schlesner, M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics 32, 2847\u20132849. https:\/\/doi.org\/10.1093\/bioinformatics\/btw313 (2016).","journal-title":"Bioinformatics"},{"key":"17725_CR23","doi-asserted-by":"publisher","DOI":"10.1101\/2020.09.14.296152","volume-title":"Mapping of Safe and Early Chemo-attenuated Live Plasmodium falciparum Immunization Identifies Immune Signature of Vaccine Efficacy","author":"S Borrmann","year":"2020","unstructured":"Borrmann, S. et al. Mapping of Safe and Early Chemo-attenuated Live Plasmodium falciparum Immunization Identifies Immune Signature of Vaccine Efficacy (Cold Spring Harbor Laboratory, 2020)."},{"key":"17725_CR24","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1038\/s41467-021-22740-w","volume":"12","author":"Z Sulyok","year":"2021","unstructured":"Sulyok, Z. et al. Heterologous protection against malaria by a simple chemoattenuated PfSPZ vaccine regimen in a randomized trial. Nat. Commun. 12, 2518. https:\/\/doi.org\/10.1038\/s41467-021-22740-w (2021).","journal-title":"Nat. Commun."},{"key":"17725_CR25","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1093\/biostatistics\/kxn042","volume":"10","author":"JD Silver","year":"2009","unstructured":"Silver, J. D., Ritchie, M. E. & Smyth, G. K. Microarray background correction: Maximum likelihood estimation for the normal-exponential convolution. Biostatistics 10, 352\u2013363. https:\/\/doi.org\/10.1093\/biostatistics\/kxn042 (2009).","journal-title":"Biostatistics"},{"key":"17725_CR26","doi-asserted-by":"publisher","first-page":"D539","DOI":"10.1093\/nar\/gkn814","volume":"37","author":"C Aurrecoechea","year":"2009","unstructured":"Aurrecoechea, C. et al. PlasmoDB: A functional genomic database for malaria parasites. Nucleic Acids Res. 37, D539\u2013D543. https:\/\/doi.org\/10.1093\/nar\/gkn814 (2009).","journal-title":"Nucleic Acids Res."},{"key":"17725_CR27","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing v. 4.0.2 (R Foundation for Statistical Computing, 2020)."},{"key":"17725_CR28","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.21105\/joss.01686","volume":"4","author":"H Wickham","year":"2019","unstructured":"Wickham, H. et al. Welcome to the Tidyverse. J. Open Source Softw. 4, 1686. https:\/\/doi.org\/10.21105\/joss.01686 (2019).","journal-title":"J. Open Source Softw."},{"key":"17725_CR29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1128\/cmr.00025-08","volume":"22","author":"DL Doolan","year":"2009","unstructured":"Doolan, D. L., Doba\u00f1O, C. & Baird, J. K. Acquired immunity to malaria. Clin. Microbiol. Rev. 22, 13\u201336. https:\/\/doi.org\/10.1128\/cmr.00025-08 (2009).","journal-title":"Clin. Microbiol. Rev."},{"key":"17725_CR30","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/nm.4110","volume":"22","author":"AS Ishizuka","year":"2016","unstructured":"Ishizuka, A. S. et al. Protection against malaria at 1 year and immune correlates following PfSPZ vaccination. Nat. Med. 22, 614\u2013623. https:\/\/doi.org\/10.1038\/nm.4110 (2016).","journal-title":"Nat. Med."},{"key":"17725_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01008","author":"G Moncunill","year":"2017","unstructured":"Moncunill, G. et al. RTS, S\/AS01E malaria vaccine induces memory and polyfunctional T cell responses in a pediatric African Phase III Trial. Front. Immunol. https:\/\/doi.org\/10.3389\/fimmu.2017.01008 (2017).","journal-title":"Front. Immunol."},{"key":"17725_CR32","doi-asserted-by":"publisher","first-page":"6720","DOI":"10.1016\/j.vaccine.2017.10.012","volume":"35","author":"R Perraut","year":"2017","unstructured":"Perraut, R. et al. Association of antibodies to Plasmodium falciparum merozoite surface protein-4 with protection against clinical malaria. Vaccine 35, 6720\u20136726. https:\/\/doi.org\/10.1016\/j.vaccine.2017.10.012 (2017).","journal-title":"Vaccine"},{"key":"17725_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1009801","volume":"18","author":"MT Naung","year":"2022","unstructured":"Naung, M. T. et al. Global diversity and balancing selection of 23 leading Plasmodium falciparum candidate vaccine antigens. PLoS Comput. Biol. 18, e1009801. https:\/\/doi.org\/10.1371\/journal.pcbi.1009801 (2022).","journal-title":"PLoS Comput. Biol."},{"key":"17725_CR34","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1146\/annurev-immunol-032713-120220","volume":"32","author":"PD Crompton","year":"2014","unstructured":"Crompton, P. D. et al. Malaria immunity in man and mosquito: Insights into unsolved mysteries of a deadly infectious disease. Annu. Rev. Immunol. 32, 157\u2013187. https:\/\/doi.org\/10.1146\/annurev-immunol-032713-120220 (2014).","journal-title":"Annu. Rev. Immunol."},{"key":"17725_CR35","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.3389\/fimmu.2018.02973","volume":"9","author":"K Deroost","year":"2018","unstructured":"Deroost, K. & Langhorne, J. Gamma\/delta T cells and their role in protection against malaria. Front. Immunol. 9, 2973. https:\/\/doi.org\/10.3389\/fimmu.2018.02973 (2018).","journal-title":"Front. Immunol."},{"key":"17725_CR36","doi-asserted-by":"publisher","first-page":"251ra117","DOI":"10.1126\/scitranslmed.3009793","volume":"6","author":"P Jagannathan","year":"2014","unstructured":"Jagannathan, P. et al. Loss and dysfunction of V\u03b42+ \u03b3\u03b4 T cells are associated with clinical tolerance to malaria. Sci. Transl. Med. 6, 251ra117. https:\/\/doi.org\/10.1126\/scitranslmed.3009793 (2014).","journal-title":"Sci. Transl. Med."},{"key":"17725_CR37","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/ni.f.205","volume":"9","author":"J Langhorne","year":"2008","unstructured":"Langhorne, J., Ndungu, F. M., Sponaas, A.-M. & Marsh, K. Immunity to malaria: More questions than answers. Nat. Immunol. 9, 725\u2013732. https:\/\/doi.org\/10.1038\/ni.f.205 (2008).","journal-title":"Nat. Immunol."},{"key":"17725_CR38","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.parint.2018.10.012","volume":"69","author":"T Tohmoto","year":"2019","unstructured":"Tohmoto, T. et al. Anti-MSP11 IgG inhibits Plasmodium falciparum merozoite invasion into erythrocytes in vitro. Parasitol. Int. 69, 25\u201329. https:\/\/doi.org\/10.1016\/j.parint.2018.10.012 (2019).","journal-title":"Parasitol. Int."},{"key":"17725_CR39","doi-asserted-by":"publisher","first-page":"6348060","DOI":"10.1155\/2019\/6348060","volume":"2019","author":"A Gaballa","year":"2019","unstructured":"Gaballa, A., Arruda, L. C. M., R\u00e5destad, E. & Uhlin, M. CD8<sup>+<\/sup><i>\u03b3\u03b4<\/i> T cells are more frequent in CMV seropositive bone marrow grafts and display phenotype of an adaptive immune response. Stem Cells Int. 2019, 6348060. https:\/\/doi.org\/10.1155\/2019\/6348060 (2019).","journal-title":"Stem Cells Int."},{"key":"17725_CR40","doi-asserted-by":"publisher","first-page":"4584","DOI":"10.4049\/jimmunol.1601146","volume":"197","author":"M Kadivar","year":"2016","unstructured":"Kadivar, M., Petersson, J., Svensson, L. & Marsal, J. CD8\u03b1\u03b2+ \u03b3\u03b4 T Cells: A novel T cell subset with a potential role in inflammatory bowel disease. J. Immunol. 197, 4584. https:\/\/doi.org\/10.4049\/jimmunol.1601146 (2016).","journal-title":"J. Immunol."},{"key":"17725_CR41","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ebiom.2018.11.053","volume":"39","author":"W Xu","year":"2019","unstructured":"Xu, W. et al. Mapping of \u03b3\/\u03b4 T cells reveals V\u03b42+ T cells resistance to senescence. EBioMedicine 39, 44\u201358. https:\/\/doi.org\/10.1016\/j.ebiom.2018.11.053 (2019).","journal-title":"EBioMedicine"},{"key":"17725_CR42","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/eji.201040905","volume":"41","author":"A Debarros","year":"2011","unstructured":"Debarros, A., Chaves-Ferreira, M., D\u2019Orey, F., Ribot, J. C. & Silva-Santos, B. CD70-CD27 interactions provide survival and proliferative signals that regulate T cell receptor-driven activation of human \u03b3\u03b4 peripheral blood lymphocytes. Eur. J. Immunol. 41, 195\u2013201. https:\/\/doi.org\/10.1002\/eji.201040905 (2011).","journal-title":"Eur. J. Immunol."},{"key":"17725_CR43","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jdermsci.2011.06.004","volume":"63","author":"T Honda","year":"2011","unstructured":"Honda, T., Miyachi, Y. & Kabashima, K. Regulatory T cells in cutaneous immune responses. J. Dermatol. Sci. 63, 75\u201382. https:\/\/doi.org\/10.1016\/j.jdermsci.2011.06.004 (2011).","journal-title":"J. Dermatol. Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-17725-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-17725-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-17725-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T05:37:16Z","timestamp":1669354636000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-17725-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,3]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["17725"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-17725-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,3]]},"assertion":[{"value":"4 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"SLH has a financial interest in Sanaria Inc., which is the developer and owner of PfSPZ Challenge and the sponsor of the clinical trial. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13303"}}